Canada Markets closed

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
53.91-0.08 (-0.15%)
At close: 04:03PM EDT
53.85 -0.06 (-0.11%)
After hours: 07:12PM EDT
Sign in to post a message.
  • T
    Tom
    Reading about people grabbing multi-figures monthly as incomes in crypto investments even in this crazy days in the market, any way or any pointers on how to make substantial progress in earning ? would appreciate
  • l
    louis
    only 68 mil share shorted need cover at end of the month .next 2 week dividend on 6/10/22
    and more buy back stock could see 57s
  • J
    Jay
    "[F]or any given viral copy number," the odds of developing those antibodies were 13.67 times higher for the unvaccinated. A placebo recipient with a mild infection had a 71% chance of developing those antibodies, compared to 15% for a vaccine recipient. The two only start to converge at the highest viral loads.

    "While an increase in seroreversion cannot be ruled out, given the short time frame the more likely explanation is a vaccine-induced reduction in seroconversion," or development of antibodies, the researchers wrote.
  • G
    GERRY
    Ooo gee, look PFE is sitting out another rally. LOL
    Will dump at $57.00 this time. Rinse, repeat
  • C
    Carter g
    Not able to understand the reaction for yesterday and today. Everyone knew that the interest rates are going up by 50 basis points. Why the markets went up 3% after the FED announcement and then came down 5% the next day? Makes absolutely no sense. It looks like as if we got hit by something unexpected. One thing is sure the market will keep swinging wildly before it sets a direction.
  • B
    Brent
    Going up today. Huge news from the Arena acquisition. Potential to challenge Humira?
  • P
    Peppino
    PFE is making a positive impact on world health by making medicine and vaccine available at cost, to poorer nations.The public image of PFE will greatly benefit.Good Move.
  • M
    Mr. Handsome
    What is wrong with this stock.. A top line pharma company like this should be pricing well above where it is now. A PE of 12... its peers are 100+ dollars stocks and PFE hasn't seen a big push up in a LONG LONG time. Maybe time for a management change?
  • S
    Steve
    So, in other words, the jab only works for a handful of months, and then you have to take another. And another. And another. According to the U.S. Centers for Disease Control and Prevention,15 the first two doses wear off after five months, necessitating a third dose, and the third dose wears off in just four months, at which time you’re supposed to get dose No. 4.

    Israeli data16 show the effectiveness of shot No. 4 in preventing severe disease declines by 56% in just seven weeks. So, it appears the protection you get from the shots keeps getting shorter with each dose. Meanwhile, data show the shots can render you increasingly susceptible to all manner of infection and disease, through a wide variety of mechanisms.
  • G
    Greg
    Longs need to go out and get your 4th booster now !!! Take your medicine NOW !!! Enjoy the ride.
  • S
    Steve
    Boosted Now Have Three to Four Times Higher Case Rates
    The Defender also reviews other U.K. data showing the COVID case rate is three to four times higher among those who have received a booster shot, compared to the unvaccinated. This is true for all age groups with the exception of children under 18.
  • G
    Gregg
    I disagree with Yahoo Finances indicating PFE is overvalued. The current PE is 11.78. That is lower than MRK at 16.61 and JNJ at 23.15. All three are good companies and I think YF price target for PFE is a little low. I think 62 is well within reach.
  • l
    louis
    wow PFE is 50% under value , the fair value is $104 for earning and PE forward 7
    buy and hold my target is $65 end of the year
  • l
    louis
    in next few weeks PFE could break out resistance at 53.56 and next resistance at 55.91
    65 targets for next earning report . stock 50% under value
  • M
    Mark
    Vaxing babies soon for covid19. Will be vaxing for everything soon. Do they move on to the common cold? Or probably more money in cold medicine. ? Probably. Hope they do something profitable with this Covid19 windfall as covid19 hopefully becomes less of a problem. How is Pfizer pipeline???
  • D
    Dave01245
    PFE: the only Green on my screen. "100% truth"
  • n
    noah
    “But there’s another piece of the immunity puzzle that scientists are urgently trying to solve, and that is whether some of this drop off in our protection may be a result of the mRNA technology used to build some Covid-19 vaccines, such as those developed by Moderna and Pfizer/BioNTech, which were the first in the world to use this platform.”

    Vaccine cheerleader Dr. Anthony Fauci, who has pushed the mRNA vaccines for close to two years, contributed to the article, this time claiming, “Some vaccine platforms give a very high degree of protection but the durability isn’t very long.”

    He then threw the failed experimental mRNA technology under the bus saying, “We got a really great platform with mRNA… But let’s try to be better.”

    The talking point was also espoused on “Good Morning America” of all places last week, with an ABC News senior medical contributor admitting the mRNA vaccines and subsequent boosters could be destroying immune systems. It seems Pfizer Covid Jab kills more people than it helps.
  • d
    donna
    Good dividend, growing pipeline and pursuing acquisitions! Buy and hold.
  • T
    Terminal Gravity
    PFE is setting up so nicely. Short interest increased 9% to 68M shares while MFI has been trending up and stock looks ready to break above 50 DSMA of $50.89. Fundamentally, PFE should be at least trading at $70+. The sheety markets have held us down. That will change. Accumulating.
  • S
    Steve
    The Biden Administration and the FDA authorized the experimental vaccine for children in this age group in November of 2021. In just three short months, enough children had become vaccinated and the case rate flipped. Any protection the jab provided quickly wore off, making the fully vaccinated children more susceptible to and more likely to spread the virus than the unvaccinated.

    In all, there are over 28 million children aged 5-11 in the United States. Unfortunately, a whopping ~8 million of them (or 28.8%) have been fully vaccinated already, according to the Mayo Clinic. Not only is the virus proven to be effectively non-lethal for children, especially ones of this young age (99.995% or higher recovery rate), but the experimental vaccine has proven to have negative effectiveness – aka higher infection rate – across multiple age groups.